KLEE, M., AHO, V., MAY, P., Heintz-Buschart, A., LANDOULSI, Z., JONSDOTTIR, S., PAULY, C., PAVELKA, L., DELACOUR, L., KAYSEN, A., Krüger, R., WILMES, P., LEIST, A., Acharya, G., Aguayo, G., Alexandre, M., ALI, M., Ammerlann, W., ARENA, G., ... ZELIMKHANOV, G. (2024). Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome. Journal of Prevention of Alzheimer's Disease. doi:10.14283/jpad.2024.19 Peer reviewed |
TALAVERA ANDUJAR, B., MARY, A., VENEGAS MALDONADO, C. J., Cheng, T., Zaslavsky, L., Bolton, E., HENEKA, M., & SCHYMANSKI, E. (2023). Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients? (2). ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/58891. doi:10.26434/chemrxiv-2023-6j2gm-v2 |
Stark, M., Wolfsgruber, S., Kleineidam, L., Frommann, I., Altenstein, S., Bartels, C., Brosseron, F., Buerger, K., Burow, L., Butryn, M., Ewers, M., Fliessbach, K., Gabelin, T., Glanz, W., Goerss, D., Gref, D., Hansen, N., HENEKA, M., Hinderer, P., ... Wagner, M. (21 November 2023). Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline. Neurology, 101 (21), 2185 - e2196. doi:10.1212/WNL.0000000000207844 Peer Reviewed verified by ORBi |
DADWAL, S., & HENEKA, M. (2023). Microglia heterogeneity in health and disease. FEBS Open Bio. doi:10.1002/2211-5463.13735 Peer Reviewed verified by ORBi |
Bartsch, T., Berg, D., HENEKA, M., & Leypoldt, F. (October 2023). Parkinson- und Alzheimer-Erkrankung als Systemerkrankungen. Nervenarzt, 94 (10), 875 - 884. doi:10.1007/s00115-023-01542-z Peer Reviewed verified by ORBi |
Waschkies, K. F., Soch, J., Darna, M., Richter, A., Altenstein, S., Beyle, A., Brosseron, F., Buchholz, F., Butryn, M., Dobisch, L., Ewers, M., Fliessbach, K., Gabelin, T., Glanz, W., Goerss, D., Gref, D., Janowitz, D., Kilimann, I., Lohse, A., ... Kizilirmak, J. M. (October 2023). Machine learning-based classification of Alzheimer's disease and its at-risk states using personality traits, anxiety, and depression. International Journal of Geriatric Psychiatry, 38 (10), 6007. doi:10.1002/gps.6007 Peer Reviewed verified by ORBi |
TALAVERA ANDUJAR, B., MARY, A., VENEGAS MALDONADO, C. J., Cheng, T., Zaslavsky, L., Bolton, E. E., HENEKA, M., & SCHYMANSKI, E. (21 September 2023). YoungNMC 2023: "Challenges in Developing Non-target Exposomics and Metabolomics Workflows for Cerebrospinal Fluid from Alzheimer's disease and Mild Cognitive Impairment" [Paper presentation]. YoungNMC Symposium, Nijmegen, Netherlands. doi:10.5281/ZENODO.8364324 Peer reviewed |
Karabag, D., Scheiblich, H., Griep, A., Santarelli, F., Schwartz, S., HENEKA, M., & Ising, C. (August 2023). Characterizing microglial senescence: Tau as a key player. Journal of Neurochemistry, 166 (3), 517 - 533. doi:10.1111/jnc.15866 Peer Reviewed verified by ORBi |
TALAVERA ANDUJAR, B., MARY, A., Cheng, T., Zaslavsky, L., Bolton, E., HENEKA, M., & SCHYMANSKI, E. (2023). Non-target LC-HRMS to Study the Exposome of Mild Cognitive Impairment and Alzheimer’s Disease on Cerebrospinal Fluid. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/57734. doi:10.26434/chemrxiv-2023-6j2gm |
TALAVERA ANDUJAR, B., MARY, A., Cheng, T., Zaslavsky, L., Bolton, E. E., HENEKA, M., & SCHYMANSKI, E. (07 June 2023). Non-target LC-HRMS to Study the Exposome of Mild Cognitive Impairment and Alzheimer's Disease on Cerebrospinal Fluid [Poster presentation]. 19th Annual International Conference of the Metabolomics Society, Niagara Falls, Canada. doi:10.5281/ZENODO.8017622 Peer reviewed |
Walker, K. A., Le Page, L. M., Terrando, N., Duggan, M. R., HENEKA, M., & Bettcher, B. M. (05 June 2023). The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap. Molecular Neurodegeneration, 18 (1), 37. doi:10.1186/s13024-023-00627-2 Peer Reviewed verified by ORBi |
Kloske, C. M., Barnum, C. J., Batista, A. F., Bradshaw, E. M., Brickman, A. M., Bu, G., Dennison, J., Gearon, M. D., Goate, A. M., Haass, C., HENEKA, M., Hu, W. T., Huggins, L. K. L., Jones, N. S., Koldamova, R., Lemere, C. A., Liddelow, S. A., Marcora, E., Marsh, S. E., ... Carrillo, M. C. (June 2023). APOE and immunity: Research highlights. Alzheimer's and Dementia: the Journal of the Alzheimer's Association, 19 (6), 2677 - 2696. doi:10.1002/alz.13020 Peer Reviewed verified by ORBi |
Stratoulias, V., Ruiz, R., Kanatani, S., Osman, A. M., Keane, L., Armengol, J. A., Rodríguez-Moreno, A., Murgoci, A.-N., García-Domínguez, I., Alonso-Bellido, I., González Ibáñez, F., Picard, K., Vázquez-Cabrera, G., Posada-Pérez, M., Vernoux, N., Tejera, D., Grabert, K., Cheray, M., González-Rodríguez, P., ... Joseph, B. (June 2023). ARG1-expressing microglia show a distinct molecular signature and modulate postnatal development and function of the mouse brain. Nature Neuroscience, 26 (6), 1008 - 1020. doi:10.1038/s41593-023-01326-3 Peer Reviewed verified by ORBi |
Bendella, Z., Widmann, C. N., Layer, J. P., Layer, Y. L., Haase, R., Sauer, M., Bieler, L., Lehnen, N. C., Paech, D., HENEKA, M., Radbruch, A., & Schmeel, F. C. (12 May 2023). Brain Volume Changes after COVID-19 Compared to Healthy Controls by Artificial Intelligence-Based MRI Volumetry. Diagnostics, 13 (10), 1716. doi:10.3390/diagnostics13101716 Peer reviewed |
Ising, C., & HENEKA, M. (May 2023). Chronic inflammation: a potential target in tauopathies. The Lancet Neurology, 22 (5), 371 - 373. doi:10.1016/S1474-4422(23)00116-3 Peer Reviewed verified by ORBi |
Braatz, C., Komes, M. P., Ravichandran, K. A., de Fragas, M. G., Griep, A., Schwartz, S., McManus, R. M., & HENEKA, M. (2023). NLRP3-directed antisense oligonucleotides reduce microglial immunoactivities in vitro. Journal of Neurochemistry. doi:10.1111/jnc.15778 Peer Reviewed verified by ORBi |
Brosseron, F., Maass, A., Kleineidam, L., Ravichandran, K. A., Kolbe, C.-C., Wolfsgruber, S., Santarelli, F., Häsler, L. M., McManus, R., Ising, C., Röske, S., Peters, O., Cosma, N.-C., Schneider, L.-S., Wang, X., Priller, J., Spruth, E. J., Altenstein, S., Schneider, A., ... DELCODE study group. (12 January 2023). Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study. Alzheimer's Research and Therapy, 15 (1), 13. doi:10.1186/s13195-022-01118-0 Peer Reviewed verified by ORBi |
Henning, L., Antony, H., Breuer, A., Müller, J., Seifert, G., Audinat, E., Singh, P., Brosseron, F., Heneka, M., Steinhäuser, C., & Bedner, P. (2023). Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfunction and acute seizures in experimental temporal lobe epilepsy. Glia, 71 (2), 168-186. doi:10.1002/glia.24265 Peer Reviewed verified by ORBi |
Heneka, M. (2023). ApoE4 makes microglia trem(2)bling. Neuron, 111 (2), 142-144. doi:10.1016/j.neuron.2022 Peer Reviewed verified by ORBi |
Teipel, S. J., Dyrba, M., Levin, F., Altenstein, S., Berger, M., Beyle, A., Brosseron, F., Buerger, K., Burow, L., Dobisch, L., Ewers, M., Fliessbach, K., Frommann, I., Glanz, W., Goerss, D., Gref, D., Hansen, N., HENEKA, M., Incesoy, E. I., ... DELCODE study group and the Alzheimer’s Disease Neuroimaging Initiative. (2023). Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach. Journal of Alzheimer's disease reports, 7 (1), 1055 - 1076. doi:10.3233/ADR-230027 Peer reviewed |
Mercan, D., & Heneka, M. (2022). The Contribution of the Locus Coeruleus-Noradrenaline System Degeneration during the Progression of Alzheimer's Disease. Biology, 11 (12). doi:10.3390/biology11121822 Peer Reviewed verified by ORBi |
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., Bennett, F., Bessis, A., Biber, K., Bilbo, S., Blurton-Jones, M., Boddeke, E., Brites, D., Brône, B., Brown, G. C., ... Wyss-Coray, T. (2022). Microglia states and nomenclature: A field at its crossroads. Neuron, 110 (21), 3458-3483. doi:10.1016/j.neuron.2022.10.020 Peer Reviewed verified by ORBi |
Brosseron, F., Maass, A., Kleineidam, L., Ravichandran, K. A., González, P. G., McManus, R. M., Ising, C., Santarelli, F., Kolbe, C.-C., Häsler, L. M., Wolfsgruber, S., Marquié, M., Boada, M., Orellana, A., de Rojas, I., Röske, S., Peters, O., Cosma, N.-C., Cetindag, A., ... Heneka, M. (2022). Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease. Neuron, 110 (6), 1009-1022.e4. doi:10.1016/j.neuron.2021.12.016 Peer Reviewed verified by ORBi |
Castro-Gomez, S., Binder, J., Schievelkamp, A.-H., & Heneka, M. (2022). CNS Superficial Siderosis Mimicking a Motor Neuron Disease. Brain Sciences, 12 (11). doi:10.3390/brainsci12111558 Peer Reviewed verified by ORBi |
Keane, L., Antignano, I., RIECHERS, S.-P. H., Zollinger, R., Dumas, A. A., Offermann, N., Bernis, M. E., Russ, J., Graelmann, F., McCormick, P. N., Esser, J., Tejera, D., Nagano, A., Wang, J., Chelala, C., Biederbick, Y., Halle, A., Salomoni, P., HENEKA, M., & Capasso, M. (15 October 2021). mTOR-dependent translation amplifies microglia priming in aging mice. Journal of Clinical Investigation, 131 (20). doi:10.1172/JCI155208 Peer Reviewed verified by ORBi |
Keane, L., Antignano, I., Riechers, S.-P. H., Zollinger, R., Dumas, A. A., Offermann, N., Bernis, M. E., Russ, J., Graelmann, F., McCormick, P. N., Esser, J., Tejera, D., Nagano, A., Wang, J., Chelala, C., Biederbick, Y., Halle, A., Salomoni, P., Heneka, M., & Capasso, M. (2021). mTOR-dependent translation amplifies microglia priming in aging mice. Journal of Clinical Investigation, 131 (1). Peer reviewed |